Trial intelligence / Profile preview

Atorvastatin 80mg for Myocardial Edema Following CABG

NCT02901379Phase 3Completed

Sponsor
National Cardiovascular Center Harapan Kita
Start
Oct 2016
Primary completion
Aug 2018
Modality
Small Molecules
01

Overview

Phase 3, randomised, double-blind trial of atorvastatin in Myocardial edema (2 arms), sponsored by National Cardiovascular Center Harapan Kita. Primary endpoint: T2 relaxation time. Started Oct 2016; status: completed.

02

Drugs

atorvastatin
03

Conditions

Myocardial edema

Beyond the preview

Go deeper on NCT02901379.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02901379.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call